PRETRANSPLANT RECIPIENT CYTOMEGALOVIRUS SEROPOSITIVITY AND HEMODIALYSIS ARE ASSOCIATED WITH DECREASED RENAL ALLOGRAFT AND PATIENT SURVIVAL

Abstract

Pretransplant CMV seropositivity is associated with decreased patient survival. Pretransplant CMV seropositivity and hemodialysis have a synergistic adverse effect on graft survival, independent of patient mortality. Additional studies are required to define mechanisms by which pretransplant CMV infection and dialysis modality may contribute to decreased allograft survival.